Zonisamide for the treatment of epilepsy

References

• Arzimanoglou A, Guerrini R, Aicardi J. Aicardi's Epilepsy in Children (3rd Edition). Lippincott Williams and Wilkins, PA, USA (2004).
   Google Scholar
• Antiepileptic Drugs (5th Edition).Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Lippincott Williams and Wilkins, PA, USA (2002).
   Google Scholar
• Shah J, Shellenberger K, Canafax DM. Zonisamide: chemistry, biotransformation and pharmacokinetics. In: Antiepileptic Drugs (5th Edition). Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Lippincott Williams and Wilkins, PA, USA, 873–879 (2002).
   Google Scholar
• MacDonald RL. Zonisamide: mechanisms of action. In: Antiepileptic Drugs (5th Edition). Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Lippincott Williams and Wilkins, PA, USA, 867–872 (2002).
   Google Scholar
• Mather GG, Shah J. Zonisamide: Drug interactions. In: Antiepileptic Drugs (5th Edition) Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Lippincott Williams and Wilkins, Philadelphia, USA, 880–884 (2002).
   Google Scholar
• Yagi K. Overview of Japanese experience: controlled and uncontrolled trials. Seizure13(Suppl.), S11–S15 (2004).
   PubMedGoogle Scholar
• Yamauchi T, Aikawa H. Efficacy of zonisamide: our experience. Seizure13(Suppl. 1), S41–S49 (2004).
   PubMed Web of Science ®Google Scholar
• Ohtahara S: Zonisamide in the management of epilepsy – Japanese experience. Epilepsy Res.68(Suppl. 2), S25–S33 (2006).
   PubMed Web of Science ®Google Scholar
• Suzuki Y: Zonisamide in West syndrome. Brain Dev.23(7), 658–661 (2001).
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Imai K, Toribe Y et al. Long-term response to zonisamide in patients with West syndrome. Neurology58(10), 1556–1559 (2002).
   PubMed Web of Science ®Google Scholar
• Yanagakia S, Ogunia H, Yoshiia K et al. Zonisamide for West syndrome: a comparison of clinical responses among different titration rate. Brain Dev.27, 286–290 (2005).
   PubMed Web of Science ®Google Scholar
• Linuma K, Haginoya K. Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey. Seizure13(Suppl.), S34–S39 (2004).
   Google Scholar
• Schmidt D, Jacob R, Loiseau P et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res.15(1), 67–73 (1993).
   PubMed Web of Science ®Google Scholar
• Brodie M. Zonisamide clinical trials: European experience. Seizure135, S66–S70 (2004).
   Google Scholar
• Brodie M, Duncan R, Vespigniani H, Solyom A, Bitenskyy V, Lucas C. Dose dependent safety and efficacy of zonisamide: a randomized, double blind, placebo-controlled study in patients with refractory partial seizures Epilepsia46(1), 31–41 (2005).
   Web of Science ®Google Scholar
• Sackellares JC, Ramsay RE, Wilder BJ, Browne TR 3rd, Shellenberger MK. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia45(6), 610–617 (2004).
   PubMed Web of Science ®Google Scholar
• Faught E, Ayala R, Montouris GG, Leppik IE, Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology57, 1774–1779 (2001).
   PubMed Web of Science ®Google Scholar
• Santos CC, Brotherton T. Use of zonisamide in pediatric patients. Pediatr. Neurol.33(1), 12–14 (2005).
   PubMed Web of Science ®Google Scholar
• Wilfong A, Schultz R. Zonisamide for absence seizures. Epilepsy Res.64, 31–34 (2005).
   PubMed Web of Science ®Google Scholar
• Wilfong AA. Zonisamide monotherapy for epilepsy in children and young adults. Pediatr. Neurol.32, 77–80 (2005).
   PubMed Web of Science ®Google Scholar
• Kothare SV, Kaleyias J, Mostofi N et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr. Neurol.34(5), 351–354 (2006).
   PubMed Web of Science ®Google Scholar
• Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord.6(4), 267–270 (2004).
   PubMed Web of Science ®Google Scholar
• Ohtahara S, Yamatogi Y. Safety of zonisamide therapy: prospective follow-up survey. Seizure13(Suppl.), S50–S55 (2004).
   PubMed Web of Science ®Google Scholar
• Seino M, Ohkumo T, Miyasaka M et al. Efficacy evaluation of AD-810: results of a double blind comparison with carbamazepine. J. Clin. Exp. Med.144, 275–291 (1988). [In Japanese]
   Google Scholar
• Leppik IE. Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Res.68(Suppl 2), S17–S24 (2006).
   PubMed Web of Science ®Google Scholar
• Low PA, James S, Peschel T, Leong R, Rothstein A. Zonisamide and associated oligohidrosis and hyperthermia. Epilepsy Res.62, 27–34 (2004).
   PubMed Web of Science ®Google Scholar
• Kondo T, Kaneko S, Amano Y et al. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia37, 1241–1244 (1996).
   Google Scholar
• Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst. Rev.19(4), CD0014 (2005).
   Google Scholar